Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

31.20 -1.55 (-4.73%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More ↗

September 14, 2024

Financial factors aren't the only things that are worth paying attention to.

Via The Motley Fool

After Moderna's Shocking News, Is the Stock a Buy or a Sell? ↗

September 14, 2024

Moderna held its annual R&D day this week.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 13, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target ↗

September 13, 2024

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028,...

Via Benzinga

16 Analysts Have This To Say About Moderna ↗

September 13, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years ↗

September 13, 2024

Via Benzinga

Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day ↗

September 13, 2024

Via Benzinga

Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday ↗

September 13, 2024

Via Benzinga

Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day ↗

September 13, 2024

The company offered a series of updates that shook shares on Thursday. The selloff continued on Friday.

Via Investor's Business Daily

Should You Buy Novavax Stock After This Regulatory Win? ↗

September 13, 2024

The biotech continues to earn important wins, but is it enough?

Via The Motley Fool

A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now ↗

September 13, 2024

These players have had their ups and downs -- but the future looks bright.

Via The Motley Fool

Wall Street Eyes Strong Finish To The Week Despite Futures Suggesting Moderation In Tech Buying: Strategist Cautions Against Factoring Rapid, Steep Cuts Ahead Of Next Week's Fed Meeting ↗

September 13, 2024

Now that the twin inflation reports are in the rearview mirror, U.S. stocks are hanging onto the slender optimism as traders look ahead to the Federal Reserve’s rate-setting meeting.

Via Benzinga

Topics Economy

Moderna R&D Day Highlights Progress and Strategic Priorities

September 12, 2024

Via ACCESSWIRE

Check Out What Whales Are Doing With MRNA ↗

September 10, 2024

Via Benzinga

A Closer Look at Moderna's Options Market Dynamics ↗

September 09, 2024

Via Benzinga

Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns ↗

September 12, 2024

Moderna announced plans to slash its R&D budget by $1.1 billion by 2027.

Via Talk Markets

Why Are Novavax Shares Trading Lower Today? ↗

September 12, 2024

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.

Via Benzinga

Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday? ↗

September 12, 2024

At midday on Thursday, Wall Street was showing slight gains, with small caps leading the charge. The Russell 2000 index surged 1.2%, outperforming large-cap indices in a notable rebound.

Via Benzinga

Topics Economy

Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations ↗

September 12, 2024

Moderna highlights its mRNA pipeline and financial strategy at R&D Day and aims for 10 product approvals by 2027, expects to reduce R&D spending by $1.1 billion, and projects profitability for its...

Via Benzinga

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

September 09, 2024

Via ACCESSWIRE

Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision ↗

September 12, 2024

U.S. stocks could open Thursday’s session modestly higher after the remarkable recovery they staged in the previous session. The spotlight is on the producer price inflation report for August as...

Via Benzinga

Topics Economy Stocks

Moderna To Slash $1.1 Billion From R&D Spending In Major Commercial Push ↗

September 12, 2024

The company says it's investment in R&D has paid off. Now, it needs to move its focus to launching new products.

Via Investor's Business Daily

3 No-Brainer Biotech Stocks to Buy With $200 Right Now ↗

September 12, 2024

An investment in these players today could score a big win down the road.

Via The Motley Fool

GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech ↗

September 11, 2024

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clinical trials. Moderna and Pfizer's partner BioNTech are still developing HSV...

Via Benzinga

Is Hims & Hers Health the Next Teladoc? ↗

September 11, 2024

Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 09, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 09, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday? ↗

September 09, 2024

U.S. stocks started the new week with strong gains, as all major indices and sectors in the S&P 500 were in the green by midday in New York. This comes after Wall Street experienced its worst week of...

Via Benzinga

Topics Stocks

Why Is Moderna Stock Trading Higher On Monday? ↗

September 09, 2024

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vaccines domestically by 2025. The site will manufacture COVID-19, RSV, and flu...

Via Benzinga

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

September 09, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.